| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;96:2455-2461.)
© 1997 American Heart Association, Inc.
Articles |
From the Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services (B.M.P.) and Department of Biostatistics (R.A.K.), University of Washington, Seattle; Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Md (T.A.M.); Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh (Pa) (L.H.K.); Department of Medicine, University of Vermont, Burlington (M.C.); Departments of Medicine and Epidemiology, The Johns Hopkins University, Baltimore, Md (L.P.F.); Department of Medicine, University of California at Davis (R.W.); and Department of Public Health Sciences, Bowman Gray School of Medicine (C.D.F., P.M.R.), Winston-Salem, NC.
Background This study aimed to describe the incidence of atrial fibrillation (AF) among older adults during 3 years of follow-up.
Methods and Results In this cohort study, 5201 adults
65
years old were examined annually on four occasions between June 1989
and May 1993. At baseline, participants answered questionnaires and
underwent a detailed examination that included carotid ultrasound,
pulmonary function tests, ECG, and
echocardiography. Subjects with a pacemaker or AF
at baseline (n=357) were excluded. New cases of AF were identified from
three sources: (1) annual self-reports, (2) annual ECGs, and (3)
hospital discharge diagnoses. Cox proportional-hazards models were used
to assess baseline risk factors as predictors of incident AF. Among
4844 participants, 304 developed a first episode of AF during an
average follow-up of 3.28 years, for an incidence of 19.2 per 1000
person-years. The onset was strongly associated with age, male sex, and
the presence of clinical cardiovascular disease. For
men 65 to 74 and 75 to 84 years old, the incidences were 17.6 and 42.7,
respectively, and for women, 10.1 and 21.6 events per 1000
person-years. In stepwise models, the use of diuretics, a
history of valvular heart disease, coronary disease,
advancing age, higher levels of systolic blood pressure,
height, glucose, and left atrial size were all associated with an
increased risk of AF. The use of ß-blockers and high levels of
alcohol use, cholesterol, and forced expiratory volume in 1
second were associated with a reduced risk of AF.
Conclusions The incidence of AF in older adults may be higher than estimated by previous population studies. Left atrial size appears to be an important risk factor, and the control of blood pressure and glucose may be important in preventing the development of AF.
Key Words: fibrillation atrial flutter epidemiology follow-up studies risk factors
This article has been cited by other articles:
![]() |
D. R. Holmes Jr and R. S. Schwartz Left Atrial Appendage Occlusion Eliminates the Need for Warfarin Circulation, November 10, 2009; 120(19): 1919 - 1926. [Full Text] [PDF] |
||||
![]() |
R. P. Whitlock, J. S. Healey, and S. J. Connolly Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin Circulation, November 10, 2009; 120(19): 1927 - 1932. [Full Text] [PDF] |
||||
![]() |
K. K. Patton, P. T. Ellinor, S. R. Heckbert, R. H. Christenson, C. DeFilippi, J. S. Gottdiener, and R. A. Kronmal N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study Circulation, November 3, 2009; 120(18): 1768 - 1774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Viles-Gonzalez and J. L. Halperin Everything Counts in Large Amounts: Device-Detected Atrial High-Rate Arrhythmias Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 471 - 473. [Full Text] [PDF] |
||||
![]() |
G. A. Nichols, K. Reinier, and S. S. Chugh Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation Diabetes Care, October 1, 2009; 32(10): 1851 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Borg, K. A. Pearce, S. G. Williams, and S. G. Ray Left atrial function and deformation in chronic primary mitral regurgitation Eur J Echocardiogr, October 1, 2009; 10(7): 833 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Patel, G.-X. Yan, and P. R. Kowey Dronedarone Circulation, August 18, 2009; 120(7): 636 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cheng, M. J. Keyes, M. G. Larson, E. L. McCabe, C. Newton-Cheh, D. Levy, E. J. Benjamin, R. S. Vasan, and T. J. Wang Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block JAMA, June 24, 2009; 301(24): 2571 - 2577. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rosengren, P. J. Hauptman, G. Lappas, L. Olsson, L. Wilhelmsen, and K. Swedberg Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men Eur. Heart J., May 1, 2009; 30(9): 1113 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C B De Vos, B Weijs, H J G M Crijns, E C Cheriex, A Palmans, J Habets, M H Prins, R Pisters, R Nieuwlaat, and R G Tieleman Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation Heart, May 1, 2009; 95(10): 835 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Conen, U. B. Tedrow, B. A. Koplan, R. J. Glynn, J. E. Buring, and C. M. Albert Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women Circulation, April 28, 2009; 119(16): 2146 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Z. Soliman, R. J. Prineas, L. D. Case, Z.-m. Zhang, and D. C. Goff Jr Ethnic Distribution of ECG Predictors of Atrial Fibrillation and Its Impact on Understanding the Ethnic Distribution of Ischemic Stroke in the Atherosclerosis Risk in Communities (ARIC) Study Stroke, April 1, 2009; 40(4): 1204 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nucifora, J. D. Schuijf, L. F. Tops, J. M. van Werkhoven, S. Kajander, J. W. Jukema, J. H.M. Schreur, M. W. Heijenbrok, S. A. Trines, O. Gaemperli, et al. Prevalence of Coronary Artery Disease Assessed by Multislice Computed Tomography Coronary Angiography in Patients With Paroxysmal or Persistent Atrial Fibrillation Circ Cardiovasc Imaging, March 1, 2009; 2(2): 100 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Benjamin, P.-S. Chen, D. E. Bild, A. M. Mascette, C. M. Albert, A. Alonso, H. Calkins, S. J. Connolly, A. B. Curtis, D. Darbar, et al. Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop Circulation, February 3, 2009; 119(4): 606 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E.B. Balbao, A. A.V. de Paola, and G. Fenelon Effects of alcohol on atrial fibrillation: myths and truths Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 53 - 63. [Abstract] [PDF] |
||||
![]() |
T. Imamura, Y. Doi, H. Arima, K. Yonemoto, J. Hata, M. Kubo, Y. Tanizaki, S. Ibayashi, M. Iida, and Y. Kiyohara LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population: The Hisayama Study Stroke, February 1, 2009; 40(2): 382 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Conen, U. B. Tedrow, N. R. Cook, M. V. Moorthy, J. E. Buring, and C. M. Albert Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women JAMA, December 3, 2008; 300(21): 2489 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, K. Wachtell, S. E. Kjeldsen, S. Julius, L. H. Lindholm, B. Dahlof, D. A. Hille, M. S. Nieminen, J. M. Edelman, and R. B. Devereux Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients: The LIFE Study Circ Arrhythm Electrophysiol, December 1, 2008; 1(5): 337 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Beukema, H. T. Sie, A. R. Ramdat Misier, P. P. H.M. Delnoy, H. J.J. Wellens, and A. Elvan Intermediate to Long-Term Results of Radiofrequency Modified Maze Procedure as an Adjunct to Open-Heart Surgery Ann. Thorac. Surg., November 1, 2008; 86(5): 1409 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Remes, T. J. van Brakel, G. Bolotin, C. Garber, M. M. de Jong, F. H. van der Veen, and J. G. Maessen Persistent atrial fibrillation in a goat model of chronic left atrial overload. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1005 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Groh, O. A. Binns, H. G. Burton III, G. L. Champsaur, S. W. Ely, and A. M. Johnson Epicardial Ultrasonic Ablation of Atrial Fibrillation During Concomitant Cardiac Surgery Is a Valid Option in Patients With Ischemic Heart Disease Circulation, September 30, 2008; 118(14_suppl_1): S78 - S82. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S.M. Tsang, M. E. Barnes, Y. Miyasaka, S. S. Cha, K. R. Bailey, G. C. Verzosa, J. B. Seward, and B. J. Gersh Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years Eur. Heart J., September 2, 2008; 29(18): 2227 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mozaffarian, C. D. Furberg, B. M. Psaty, and D. Siscovick Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study Circulation, August 19, 2008; 118(8): 800 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Bhavnani, C. I. Coleman, C. M. White, C. A. Clyne, R. Yarlagadda, D. Guertin, and J. Kluger Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy Europace, July 1, 2008; 10(7): 854 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Schoonderwoerd, M. D. Smit, L. Pen, and I. C. Van Gelder New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation' Europace, June 1, 2008; 10(6): 668 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Vagaonescu, A. C. Wilson, and J. B. Kostis Atrial Fibrillation and Isolated Systolic Hypertension: The Systolic Hypertension in the Elderly Program and Systolic Hypertension in the Elderly Program-Extension Study Hypertension, June 1, 2008; 51(6): 1552 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kourliouros, A. De Souza, N. Roberts, A. Marciniak, A. Tsiouris, O. Valencia, J. Camm, and M. Jahangiri Dose-Related Effect of Statins on Atrial Fibrillation After Cardiac Surgery Ann. Thorac. Surg., May 1, 2008; 85(5): 1515 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Molina, L. Mont, J. Marrugat, A. Berruezo, J. Brugada, J. Bruguera, C. Rebato, and R. Elosua Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study Europace, May 1, 2008; 10(5): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sakabe, A. Shiroshita-Takeshita, A. Maguy, B. J.J.M. Brundel, A. Fujiki, H. Inoue, and S. Nattel Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia Cardiovasc Res, April 1, 2008; 78(1): 63 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watanabe, N. Tanabe, T. Watanabe, D. Darbar, D. M. Roden, S. Sasaki, and Y. Aizawa Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study Circulation, March 11, 2008; 117(10): 1255 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-H. Pan, H.-M. Tsao, N.-C. Chang, Y.-J. Chen, and S.-A. Chen Aging Dilates Atrium and Pulmonary Veins: Implications for the Genesis of Atrial Fibrillation Chest, January 1, 2008; 133(1): 190 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Arriagada, A. Berruezo, L. Mont, D. Tamborero, I. Molina, B. Coll-Vinent, B. Vidal, M. Sitges, P. Berne, J. Brugada, et al. Predictors of arrhythmia recurrence in patients with lone atrial fibrillation Europace, January 1, 2008; 10(1): 9 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koistinen, M. Valtonen, J. Savola, and J. Airaksinen Thoracoscopic microwave ablation of atrial fibrillation Interactive CardioVascular and Thoracic Surgery, December 1, 2007; 6(6): 695 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F Tops, E. E van der Wall, M. J Schalij, and J. J Bax Multi-modality imaging to assess left atrial size, anatomy and function Heart, November 1, 2007; 93(11): 1461 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roshanali, M. H. Mandegar, M. A. Yousefnia, H. Rayatzadeh, F. Alaeddini, and F. Amouzadeh Prediction of Atrial Fibrillation via Atrial Electromechanical Interval After Coronary Artery Bypass Grafting Circulation, October 30, 2007; 116(18): 2012 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Varughese, A. A. Tahrani, and J. H.B. Scarpello Letter Regarding Article, "Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk" Circulation, September 4, 2007; 116(10): e339 - e339. [Full Text] [PDF] |
||||
![]() |
A. Y.-J. Shen, J. F. Yao, S. S. Brar, M. B. Jorgensen, and W. Chen Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation J. Am. Coll. Cardiol., July 24, 2007; 50(4): 309 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Varughese, A. A. Tahrani, and J. H. B. Scarpello The Putative Link Between Glycemic Control and Cardiac Arrhythmias Arch Intern Med, July 9, 2007; 167(13): 1433 - 1434. [Full Text] [PDF] |
||||
![]() |
J. I. Barzilay, J. A. Cutler, B. R. Davis, S. L. Pressel, P. K. Whelton, J. Basile, K. L. Margolis, S. T. Ong, L. S. Sadler, J. Summerson, et al. What If Chlorthalidone-Associated Hyperglycemia Develops?--Reply Arch Intern Med, July 9, 2007; 167(13): 1434 - 1435. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF] |
||||
![]() |
N. H. L. Kuijpers, H. M. M. ten Eikelder, P. H. M. Bovendeerd, S. Verheule, T. Arts, and P. A. J. Hilbers Mechanoelectric feedback leads to conduction slowing and block in acutely dilated atria: a modeling study of cardiac electromechanics Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2832 - H2853. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F Murphy, C. R Simpson, P. S Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. MacIntyre, and J. J V McMurray A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart, May 1, 2007; 93(5): 606 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Berruezo, D. Tamborero, L. Mont, B. Benito, J. M. Tolosana, M. Sitges, B. Vidal, G. Arriagada, F. Mendez, M. Matiello, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation Eur. Heart J., April 1, 2007; 28(7): 836 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Heeringa, D. A. M. van der Kuip, A. Hofman, J. A. Kors, F. J. A. van Rooij, G. Y. H. Lip, and J. C. M. Witteman Subclinical Atherosclerosis and Risk of Atrial Fibrillation: The Rotterdam Study Arch Intern Med, February 26, 2007; 167(4): 382 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Mitchell, R. S. Vasan, M. J. Keyes, H. Parise, T. J. Wang, M. G. Larson, R. B. D'Agostino Sr, W. B. Kannel, D. Levy, and E. J. Benjamin Pulse Pressure and Risk of New-Onset Atrial Fibrillation JAMA, February 21, 2007; 297(7): 709 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shiroshita-Takeshita, M. Sakabe, K. Haugan, J. K. Hennan, and S. Nattel Model-Dependent Effects of the Gap Junction Conduction-Enhancing Antiarrhythmic Peptide Rotigaptide (ZP123) on Experimental Atrial Fibrillation in Dogs Circulation, January 23, 2007; 115(3): 310 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Mattioli, S. Bonatti, and G. Mattioli Left Atrial Anatomy and Function After Conversion From Atrial Fibrillation in Hypertrophic Hearts Angiology, January 1, 2007; 57(6): 717 - 723. [Abstract] [PDF] |
||||
![]() |
S. Dublin, B. French, N. L. Glazer, K. L. Wiggins, T. Lumley, B. M. Psaty, N. L. Smith, and S. R. Heckbert Risk of New-Onset Atrial Fibrillation in Relation to Body Mass Index Arch Intern Med, November 27, 2006; 166(21): 2322 - 2328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Koch, L. Li, D. R. Van Wagoner, A. I. Duncan, A. M. Gillinov, and E. H. Blackstone Red Cell Transfusion is Associated With an Increased Risk for Postoperative Atrial Fibrillation Ann. Thorac. Surg., November 1, 2006; 82(5): 1747 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Varughese and J. H. B. Scarpello The role of deranged glucose metabolism. Arch Intern Med, September 18, 2006; 166(16): 1784 - 1785. [Full Text] [PDF] |
||||
![]() |
P. M. Okin, K. Wachtell, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, L. H. Lindholm, M. S. Nieminen, J. M. Edelman, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA, September 13, 2006; 296(10): 1242 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): 700 - 752. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030. [Full Text] [PDF] |
||||
![]() |
D. J. van Veldhuisen, H. Aass, D. El Allaf, P. H.J.M. Dunselman, L. Gullestad, M. Halinen, J. Kjekshus, L. Ohlsson, H. Wedel, J. Wikstrand, et al. Presence and development of atrial fibrillation in chronic heart failure: Experiences from the MERIT-HF Study Eur J Heart Fail, August 1, 2006; 8(5): 539 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, K. R. Bailey, W. P. Abhayaratna, J. B. Seward, and T. S.M. Tsang Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence Circulation, July 11, 2006; 114(2): 119 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Abhayaratna, J. B. Seward, C. P. Appleton, P. S. Douglas, J. K. Oh, A. J. Tajik, and T. S.M. Tsang Left Atrial Size: Physiologic Determinants and Clinical Applications J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2357 - 2363. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kehat, R. Heinrich, O. Ben-Izhak, H. Miyazaki, J. S. Gutkind, and A. Aronheim Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation Cardiovasc Res, June 1, 2006; 70(3): 543 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Hanna, B. Heeke, H. Bush, L. Brosius, D. King-Hageman, J. F. Beshai, and J. J. Langberg The Relationship Between Stature and the Prevalence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1683 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Heeringa, D. A.M. van der Kuip, A. Hofman, J. A. Kors, G. van Herpen, B. H.Ch. Stricker, T. Stijnen, G. Y.H. Lip, and J. C.M. Witteman Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur. Heart J., April 2, 2006; 27(8): 949 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Cappola, L. P. Fried, A. M. Arnold, M. D. Danese, L. H. Kuller, G. L. Burke, R. P. Tracy, and P. W. Ladenson Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults JAMA, March 1, 2006; 295(9): 1033 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Neuberger, U. Schotten, Y. Blaauw, D. Vollmann, S. Eijsbouts, A. van Hunnik, and M. Allessie Chronic Atrial Dilation, Electrical Remodeling, and Atrial Fibrillation in the Goat J. Am. Coll. Cardiol., February 7, 2006; 47(3): 644 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Mukamal, J. S. Tolstrup, J. Friberg, G. Jensen, and M. Gronbaek Alcohol Consumption and Risk of Atrial Fibrillation in Men and Women: The Copenhagen City Heart Study Circulation, September 20, 2005; 112(12): 1736 - 1742. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Olshansky, E. N. Heller, L. B. Mitchell, M. Chandler, W. Slater, M. Green, M. Brodsky, P. Barrell, H. L. Greene, and and the AFFIRM Investigators Are Transthoracic Echocardiographic Parameters Associated With Atrial Fibrillation Recurrence or Stroke?: Results From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study J. Am. Coll. Cardiol., June 21, 2005; 45(12): 2026 - 2033. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Anyukhovsky, E. A. Sosunov, P. Chandra, T. S. Rosen, P. A. Boyden, P. Danilo Jr., and M. R. Rosen Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation Cardiovasc Res, May 1, 2005; 66(2): 353 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Menzin, L. Boulanger, O. Hauch, M. Friedman, C. B. Marple, G. Wygant, J. S Hurley, S. Pezzella, and S. Kaatz Quality of Anticoagulation Control and Costs of Monitoring Warfarin Therapy Among Patients with Atrial Fibrillation in Clinic Settings: A Multi-Site Managed-Care Study Ann. Pharmacother., March 1, 2005; 39(3): 446 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lehto, S. Snapinn, K. Dickstein, K. Swedberg, M. S. Nieminen, and on behalf of the OPTIMAAL investigators Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience Eur. Heart J., February 2, 2005; 26(4): 350 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Neuberger, U. Schotten, S. Verheule, S. Eijsbouts, Y. Blaauw, A. van Hunnik, and M. Allessie Development of a Substrate of Atrial Fibrillation During Chronic Atrioventricular Block in the Goat Circulation, January 4, 2005; 111(1): 30 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Marshall, A. R. Levy, H. Vidaillet, E. Fenwick, A. Slee, G. Blackhouse, H. L. Greene, D. G. Wyse, G. Nichol, B. J. O'Brien, et al. Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation Ann Intern Med, November 2, 2004; 141(9): 653 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Frost and P. Vestergaard Alcohol and Risk of Atrial Fibrillation or Flutter: A Cohort Study Arch Intern Med, October 11, 2004; 164(18): 1993 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Leung, W. H. Bellows, and N. B. Schiller Impairment of left atrial function predicts post-operative atrial fibrillation after coronary artery bypass graft surgery Eur. Heart J., October 2, 2004; 25(20): 1836 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abidov, R. Hachamovitch, A. Rozanski, S. W. Hayes, M. M. Santos, M. G. Sciammarella, I. Cohen, J. Gerlach, J. D. Friedman, G. Germano, et al. Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1062 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lloyd-Jones, T. J. Wang, E. P. Leip, M. G. Larson, D. Levy, R. S. Vasan, R. B. D'Agostino, J. M. Massaro, A. Beiser, P. A. Wolf, et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study Circulation, August 31, 2004; 110(9): 1042 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mozaffarian, B. M. Psaty, E. B. Rimm, R. N. Lemaitre, G. L. Burke, M. F. Lyles, D. Lefkowitz, and D. S. Siscovick Fish Intake and Risk of Incident Atrial Fibrillation Circulation, July 27, 2004; 110(4): 368 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. L'Allier, A. Ducharme, P.-F. Keller, H. Yu, M.-C. Guertin, and J.-C. Tardif Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation J. Am. Coll. Cardiol., July 7, 2004; 44(1): 159 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Fox, H. Parise, R. B. D'Agostino Sr, D. M. Lloyd-Jones, R. S. Vasan, T. J. Wang, D. Levy, P. A. Wolf, and E. J. Benjamin Parental Atrial Fibrillation as a Risk Factor for Atrial Fibrillation in Offspring JAMA, June 16, 2004; 291(23): 2851 - 2855. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Israel, G. Gronefeld, J. R. Ehrlich, Y.-G. Li, and S. H. Hohnloser Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care J. Am. Coll. Cardiol., January 7, 2004; 43(1): 47 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography Ann Intern Med, December 16, 2003; 139(12): 1018 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Aviles, D. O. Martin, C. Apperson-Hansen, P. L. Houghtaling, P. Rautaharju, R. A. Kronmal, R. P. Tracy, D. R. Van Wagoner, B. M. Psaty, M. S. Lauer, et al. Inflammation as a Risk Factor for Atrial Fibrillation Circulation, December 16, 2003; 108(24): 3006 - 3010. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Damiano Jr, S. L. Gaynor, M. Bailey, S. Prasad, J. L. Cox, J. P. Boineau, and R. P. Schuessler The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the cox maze procedure J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2016 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Acebo, J. F. Val-Bernal, J. J. Gomez-Roman, and J. M. Revuelta Clinicopathologic Study and DNA Analysis of 37 Cardiac Myxomas: A 28-Year Experience Chest, May 1, 2003; 123(5): 1379 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sinno, K. Derakhchan, D. Libersan, Y. Merhi, T. K. Leung, and S. Nattel Atrial Ischemia Promotes Atrial Fibrillation in Dogs Circulation, April 15, 2003; 107(14): 1930 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Page, T. W. Tilsch, S. J. Connolly, D. J. Schnell, S. R. Marcello, W. E. Wilkinson, E. L.C. Pritchett, and for the Azimilide Supraventricular Arrhythmia Prog Asymptomatic or "Silent" Atrial Fibrillation: Frequency in Untreated Patients and Patients Receiving Azimilide Circulation, March 4, 2003; 107(8): 1141 - 1145. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |